Pharming (PHAR) Invested Capital (2019 - 2022)

Pharming's Invested Capital history spans 4 years, with the latest figure at $54.5 million for Q4 2022.

  • Quarterly results put Invested Capital at $54.5 million for Q4 2022, down 61.34% from a year ago — trailing twelve months through Dec 2025 was $54.5 million (down 72.12% YoY), and the annual figure for FY2022 was $54.5 million, down 61.34%.
  • Invested Capital for Q4 2022 was $54.5 million at Pharming, down from $140.9 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $140.9 million in Q4 2021 to a low of $175266.6 in Q4 2020.
  • The 4-year median for Invested Capital is $27.4 million (2019), against an average of $49.0 million.
  • The sharpest move saw Invested Capital surged 80283.82% in 2021, then crashed 61.34% in 2022.
  • Year by year, Invested Capital stood at $296645.9 in 2019, then plummeted by 40.92% to $175266.6 in 2020, then surged by 80283.82% to $140.9 million in 2021, then crashed by 61.34% to $54.5 million in 2022.
  • According to Business Quant data, Invested Capital over the past three periods came in at $54.5 million, $140.9 million, and $175266.6 for Q4 2022, Q4 2021, and Q4 2020 respectively.